Alert detail
LCD L39264: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — Noridian
What changed
New coverage for upper GI molecular testing effective 2025.
Who’s affected: Gastroenterology billing teams · Effective: March 13, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 7 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.